Castration radiosensitizes prostate cancer tissue by impairing DNA double-strand break repair
Authors:
- 4 November 2015
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 7 (312) , 312re11
Abstract
Chemical castration decreases Ku70 expression impairing nonhomologous end joining DNA repair and improving the radiotherapy response of prostate cancer patients.Keywords
Funding Information
- Torsten and Ragnar Söderberg Foundation
- AstraZeneca
- Prostate Cancer UK
- European Research Council
- AFA Insurance
- Swedish Cancer Society
- Swedish Research Council
- Centre for Clinical Research
- Swedish Pain Relief Foundation
- Vastmanland Research Foundation for Cancer in Vasteras
- Henning and Ida Persson Research Foundation
This publication has 29 references indexed in Scilit:
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 studyThe Lancet Oncology, 2012
- Increased Survival with Enzalutamide in Prostate Cancer after ChemotherapyNew England Journal of Medicine, 2012
- External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised studyThe Lancet Oncology, 2010
- Radiotherapy combined with hormonal therapy in prostate cancer: the state of the artCancer Management and Research, 2010
- Radiotherapy combined with hormonal therapy in prostate cancer: the state of the artCancer Management and Research, 2010
- DNA double-strand break repair: From mechanistic understanding to cancer treatmentDNA Repair, 2007
- trans Autophosphorylation at DNA-Dependent Protein Kinase's Two Major Autophosphorylation Site Clusters Facilitates End Processing but Not End JoiningMolecular and Cellular Biology, 2007
- XLF Interacts with the XRCC4-DNA Ligase IV Complex to Promote DNA Nonhomologous End-JoiningCell, 2006
- Ku Is a Novel Transcriptional Recycling Coactivator of the Androgen Receptor in Prostate Cancer CellsJournal of Biological Chemistry, 2005
- Regulation and mechanisms of mammalian double-strand break repairOncogene, 2003